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Aim
Polymorphisms in the interleukin 4 (IL4), interleukin 13
(IL13) and their corresponding receptors have previously
been found associated with systemic sclerosis (SSc). In
this study we aim to validate these previous observations
and scrutinize their effects on gene expression.
Patients and methods
We genotyped a cohort consisting of 1902 systemic sclero-
sis patients and 1503 healthy controls, derived from
France, The Netherlands, Spain, United Kingdom, Italy
and Germany. Taqman assays were used for genotyping
three SNPs correlating with IL-4 and receptor; interleukin
4 alpha receptor Q576R (rs1801275), interleukin 4 RI75V
(rs1805010), and −590C/T (rs2243250). In the Il-13 gene
the following SNPs were genotyped; R130Q (rs20541),
(-1112C/T), rs1800925 and rs6646259 (base 43163:G/A).
In addition, we investigated the effect of these polymorph-
isms on corresponding gene expression with RT-PCR in B
cells, T cells, plasmacytoid dendritic cells, monocytes and
myeloid dendritic cells.
Results
None of these polymorphisms was found to be enriched in
the SSc population or in any SSc clinical subtype. In addi-
tion, we did not observe an effect on expression levels in
the cell subtypes.
Conclusions
Our data show that these polymorphisms do not play a
role in SSc and do not influence gene expression levels.
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